QURE

What this means for you

Not registered yet, but its 23 Jan 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

98371742

Mark type

Stylized text

Filed

23 Jan 2024

Attorney of record

Erica R. Halstead

Goods and services

• Class 001 — Chemicals: Viral systems, gene therapy systems, and nucleic acid delivery systems, all comprised of biological preparations in the nature of viruses for use in cell cultures for non-medical, scientific research purposes; viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors and nucleic acid delivery vectors all comprised of biological preparations in the nature of viruses for use in cell cultures for non-medical, scientific research purposes
• Class 005 — Pharmaceuticals: Viral systems, gene therapy systems, nucleic acid delivery systems, all comprised of biological preparations in the nature of viruses for medical purposes; viral vectors, gene therapy vectors, nucleic acid delivery vectors, all comprised of biological preparations in the nature of viruses for medical purposes; pharmaceutical products for the treatment of diseases; biological preparations for use in medical purposes, namely, in medical and clinical gene therapy, nucleic acid-based therapy; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, gene diagnosis and gene testing; pharmaceutical preparations being prophylaxis products for use in nucleic acid-based therapy and gene therapy
• Class 042 — Scientific and technological services: Medical and scientific research, product development and consultancy in the fields of biotechnology, biology, biopharmaceutical research and development, medical science, chemistry and biochemistry; Providing medical and scientific research information and advice in the fields of biotechnology, biology, biopharmaceutical research and development, medical science, chemistry and biochemistry
• Class 044 — Medical, beauty and agricultural services: Medical treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders using gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation; Providing medical information and advice in the field of medical treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders using gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation

Owner

• uniQure IP B.V., Amsterdam, NL

Prosecution history

• 27 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 27 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 27 Mar 2026 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
• 18 Dec 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
• 18 Dec 2025 — LETTER OF SUSPENSION E-MAILED
• 18 Dec 2025 — SUSPENSION LETTER WRITTEN
• 15 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 15 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 15 Dec 2025 — ASSIGNED TO LIE
• 02 Dec 2025 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
• 09 Sept 2025 — NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
• 09 Sept 2025 — INQUIRY TO SUSPENSION E-MAILED
• 09 Sept 2025 — SUSPENSION INQUIRY WRITTEN
• 09 Sept 2025 — ASSIGNED TO EXAMINER
• 08 May 2025 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION